Literature DB >> 17560657

Neurosteroid binding sites on GABA(A) receptors.

Alastair M Hosie1, Megan E Wilkins, Trevor G Smart.   

Abstract

Controlling neuronal excitability is vitally important for maintaining a healthy central nervous system (CNS) and this relies on the activity of type A gamma-aminobutyric acid (GABA(A)) neurotransmitter receptors. Given this role, it is therefore important to understand how these receptors are regulated by endogenous modulators in the brain and determine where they bind to the receptor. One of the most potent groups of modulators is the neurosteroids which regulate the activity of synaptic and extrasynaptic GABA(A) receptors. This level of regulation is thought to be physiologically important and its dysfunction may be relevant to numerous neurological conditions. The aim of this review is to summarise those studies that over the last 20 years have focussed upon finding the binding sites for neurosteroids on GABA(A) receptors. We consider the nature of steroid binding sites in other proteins where this has been determined at atomic resolution and how their generic features were mapped onto GABA(A) receptors to help locate 2 putative steroid binding sites. Altogether, the findings strongly suggest that neurosteroids do bind to discrete sites on the GABA(A) receptor and that these are located within the transmembrane domains of alpha and beta receptor subunits. The implications for neurosteroid binding to other inhibitory receptors such as glycine and GABA(C) receptors are also considered. Identifying neurosteroid binding sites may enable the precise pathophysiological role(s) of neurosteroids in the CNS to be established for the first time, as well as providing opportunities for the design of novel drug entities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560657     DOI: 10.1016/j.pharmthera.2007.03.011

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  86 in total

Review 1.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

Review 2.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Authors:  Doodipala Samba Reddy
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

4.  Increased Superoxide Dismutase 2 by Allopregnanolone Ameliorates ROS-Mediated Neuronal Death in Mice with Pilocarpine-Induced Status Epilepticus.

Authors:  Inja Cho; Won-Joo Kim; Hyun-Woo Kim; Kyoung Heo; Byung In Lee; Yang-Je Cho
Journal:  Neurochem Res       Date:  2018-05-31       Impact factor: 3.996

Review 5.  Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.

Authors:  Kiersten S Smith; Uwe Rudolph
Journal:  Neuropharmacology       Date:  2011-07-27       Impact factor: 5.250

6.  Role of neurosteroids in the anticonvulsant activity of midazolam.

Authors:  Ashish Dhir; Michael A Rogawski
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 7.  Corticosteroids: way upstream.

Authors:  Therese Riedemann; Alexandre V Patchev; Kwangwook Cho; Osborne F X Almeida
Journal:  Mol Brain       Date:  2010-01-11       Impact factor: 4.041

Review 8.  Neurosteroids and GABAergic signaling in health and disease.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Biomol Concepts       Date:  2013-02

9.  Phosphatidylinositol 4,5-bisphosphate depletion fails to affect neurosteroid modulation of GABAA receptor function.

Authors:  Steven Mennerick; Amanda A Taylor; Charles F Zorumski
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

10.  alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids.

Authors:  N Zheleznova; A Sedelnikova; D S Weiss
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.